KNOXVILLE, Tenn. (AP) — KNOXVILLE, Tenn. (AP) — Provectus Biopharmaceuticals Inc. (PVCT) on Tuesday reported a loss of $1 million in its third quarter.

The Knoxville, Tennessee-based company said it had a loss of less than 1 cent on a per-share basis.

The biopharmaceutical posted revenue of $109,700 in the period. Its adjusted revenue was $110,000.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PVCT at https://www.zacks.com/ap/PVCT